| Emerging strategies in targeting tumor-resident myeloid cells for cancer immunotherapy Y Wang, KCC Johnson, ME Gatti-Mays, Z Li Journal of hematology & oncology 15 (1), 118, 2022 | 63 | 2022 |
| Vaccinia E5 is a major inhibitor of the DNA sensor cGAS N Yang, Y Wang, P Dai, T Li, C Zierhut, A Tan, T Zhang, JZ Xiang, ... Nature communications 14 (1), 2898, 2023 | 20 | 2023 |
| Elucidating mechanisms of antitumor immunity mediated by live oncolytic vaccinia and heat-inactivated vaccinia W Wang, S Liu, P Dai, N Yang, Y Wang, RA Giese, T Merghoub, ... Journal for ImmunoTherapy of Cancer 9 (9), 2021 | 20 | 2021 |
| Lung type II alveolar epithelial cells collaborate with CCR2+ inflammatory monocytes in host defense against poxvirus infection N Yang, JM Luna, P Dai, Y Wang, CM Rice, L Deng Nature communications 13 (1), 1671, 2022 | 16 | 2022 |
| Tumor-intrinsic PRC2 inactivation drives a context-dependent immune-desert microenvironment and is sensitized by immunogenic viruses J Yan, Y Chen, AJ Patel, S Warda, CJ Lee, BG Nixon, EWP Wong, ... The Journal of Clinical Investigation 132 (17), 2022 | 13 | 2022 |
| Selective targeting of GARP-LTGFβ axis in the tumor microenvironment augments PD-1 blockade via enhancing CD8+ T cell antitumor immunity A Li, Y Chang, NJ Song, X Wu, D Chung, BP Riesenberg, M Velegraki, ... Journal for Immunotherapy of Cancer 10 (9), 2022 | 12 | 2022 |
| Scinderin is a novel transcriptional target of BRMS1 involved in regulation of hepatocellular carcinoma cell apoptosis X Qiao, Y Zhou, W Xie, Y Wang, Y Zhang, T Tian, J Dou, X Yang, S Shen, ... American Journal of Cancer Research 8 (6), 1008, 2018 | 11 | 2018 |
| OX40L-expressing recombinant modified vaccinia virus Ankara induces potent antitumor immunity via reprogramming Tregs N Yang, Y Wang, S Liu, SB Tariq, JM Luna, G Mazo, A Tan, T Zhang, ... The Journal of Experimental Medicine 220 (8), 2023 | 4 | 2023 |
| Structural transitions modulate the chaperone activities of Grp94 YS Amankwah, Y Fleifil, E Unruh, P Collins, Y Wang, K Vitou, A Bates, ... Proceedings of the National Academy of Sciences 121 (12), e2309326121, 2024 | 3 | 2024 |
| mRNA vaccines against SARS-CoV-2 induce divergent antigen-specific T-cell responses in patients with lung cancer NJ Song, KB Chakravarthy, H Jeon, C Bolyard, K Reynolds, KP Weller, ... Journal for Immunotherapy of Cancer 12 (1), 2024 | 2 | 2024 |
| Postinfusion PD-1+ CD8+ CAR T cells identify patients responsive to CD19 CAR T-cell therapy in non-Hodgkin lymphoma N Denlinger, NJ Song, X Zhang, H Jeon, C Peterson, Y Wang, ... Blood Advances 8 (12), 3140-3153, 2024 | 1 | 2024 |
| Intratumoral delivery of engineered recombinant modified vaccinia virus Ankara expressing Flt3L and OX40L generates potent antitumor immunity through activating the cGAS/STING … N Yang, Y Wang, S Liu, JM Luna, G Mazo, AY Tan, T Zhang, J Wang, ... bioRxiv, 2021.10. 31.466698, 2021 | 1 | 2021 |
| Spatial and functional targeting of intratumoral Tregs reverses CD8+ T cell exhaustion and promotes cancer immunotherapy L Zhou, M Velegraki, Y Wang, JK Mandula, Y Chang, W Liu, NJ Song, ... The Journal of Clinical Investigation, 2024 | | 2024 |
| CNPY2-orchestrated unfolded protein responses play redundant roles in regulating anti-tumor immunity of CD8+ T cells Y Wang, A Li, N Song, AE Shannon, F Hong, BC Searle, Z Li The Journal of Immunology 210 (1_Supplement), 86.12-86.12, 2023 | | 2023 |
| 920 Alteration of T cell responses against SARS-CoV-2 omicron variant after vaccination with mRNA booster in lung cancer patients K Chakravarthy, NJ Song, C Bolyard, K Reynolds, K Weller, S Reisinger, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
| 1064 Exercise induced hormone irisin inhibits Integrin αv-TGF-β axis in tumor microenvironment to improve CD8+ T cell mediated tumor control NJ Song, Y Chang, A Li, Y Wang, K Reynolds, K Weller, C Bolyard, G Xin, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
| 1445 AIM2 modulates azacytidine-induced antitumor immunity in lung cancer N Furuya, S Lu, T Okimoto, Y Wang, NJ Song, A Li, H Dong, B Zhao, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
| IL-12-expressing highly immunogenic recombinant modified vaccinia virus Ankara reprograms tumor-infiltrating myeloid cells to overcome immune resistance S Liu, G Mazo, N Yang, T Zhang, Y Wang, SB Tariq, Y Wang, ... bioRxiv, 2022.09. 25.509429, 2022 | | 2022 |
| Vaccinia virus E5 is a dominant inhibitor of the cytosolic DNA sensor cGAS N Yang, Y Wang, S Shuman, L Deng The Journal of Immunology 202 (1_Supplement), 197.8-197.8, 2019 | | 2019 |
